Sunday, September 24, 2023
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
Professor of Clinical Rheumatology
Leeds Institute of Rheumatic and Musculoskeletal Medicine
University of Leeds
Honorary Consultant Rheumatologist
Bradford Hospitals NHS Trust
Leeds, United Kingdom
Associate Professor, Harvard Medical School
Vice Chair of Clinical Trials and Innovation
Director, Center for Skin and Related Musculoskeletal Diseases
Director, Clinical Unit for Research Innovation and Trials
Department of Dermatology and Department of Medicine, Division of Rheumatology
Brigham and Women's Hospital
Boston, Massachusetts, United States
Associate Professor of Medicine
Hospital of the University of Pennsylvania
Associate Professor of Epidemiology in Biostatistics and Epidemiology
Penn Medicine
Philadelphia, Pennsylvania, United States
Doctoral Candidate
Department of Industrial Engineering and Innovation Sciences
Eindhoven University of Technology
Patient Research Partner for GRAPPA
Eindhoven, the Netherlands
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
This activity is intended for rheumatologists, dermatologists, and primary care physicians.
The goal of this activity is that learners will be better able to manage patients with psoriasis, including assessment and treatment continuation.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
Professor of Clinical Rheumatology
Leeds Institute of Rheumatic and Musculoskeletal Medicine
University of Leeds
Honorary Consultant Rheumatologist
Bradford Hospitals NHS Trust
Leeds, United Kingdom
Associate Professor, Harvard Medical School
Vice Chair of Clinical Trials and Innovation
Director, Center for Skin and Related Musculoskeletal Diseases
Director, Clinical Unit for Research Innovation and Trials
Department of Dermatology and Department of Medicine, Division of Rheumatology
Brigham and Women's Hospital
Boston, Massachusetts, United States
Associate Professor of Medicine
Hospital of the University of Pennsylvania
Associate Professor of Epidemiology in Biostatistics and Epidemiology
Penn Medicine
Philadelphia, Pennsylvania, United States
Doctoral Candidate
Department of Industrial Engineering and Innovation Sciences
Eindhoven University of Technology
Patient Research Partner for GRAPPA
Eindhoven, the Netherlands
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Developed in collaboration between Medscape and Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of
continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the
valid credit period that
is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in
your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as
the certificates from the
CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC Released: 4/4/2022
Valid for credit through: 4/4/2023, 11:59 PM EST
processing....
How will you improve your practice? Please click on the "Next" button to assess your planned changes by completing this brief survey. (Note: the following questions were developed by an independent consulting group with expertise in assessing the effectiveness of medical education.)
